ORIGINAL ARTICLE
The relationship of mast cell density in pulmonary, gastric and ovarian malignant epithelial tumors with tumor necrosis and vascularization
1
Department of Pathology, Gazi Yaşargil Education and Research Hospital, Diyarbakır, Turkey
2
Department of Gastroenterology, Dicle University, Faculty of Medicine, Diyarbakır, Turkey
3
Department of General Surgery, Faculty of Medicine, Dicle University, Diyarbakır, Turkey
4
Department of Pathology, Faculty of Medicine, Dicle University, Diyarbakır, Turkey
Submission date: 2020-01-01
Final revision date: 2020-02-07
Acceptance date: 2020-02-27
Publication date: 2020-10-25
Pol J Pathol 2020;71(3):221-228
KEYWORDS
TOPICS
ABSTRACT
Although many studies have been conducted to explore the relationship between mast cells (MC) and angiogenesis, comparison of this relationship with tumor necrosis has not been investigated to the best of our knowledge. Therefore, the relationship between MC and neovascularization in stomach, lung and ovarian malignant epithelial tumors (165 cases) in necrotizing or non-necrotizing cases was explored in this study. We immunohistochemically studied anti-mast cell tryptase antibody for MC and anti-CD34 antibody for vascular structures. MCs in the intra-
tumoral and peritumoral fields, as well as vascular structures with luminal and monocellular appearances in the intratumoral field, were counted in each sample. Ten magnification fields were analyzed for each sample. In stomach and lung cases, the non-necrotizing group exhibited a greater number of MC and vascular structures in total. In ovarian cases, more MCs were counted overall in the necrotizing group, but there were fewer vascular structures. The increase in the number of MC and vascular structures in lungs and stomach in the non-necrotizing group supports the theory that MCs are involved in tumor progression. Necrosis, which can be induced on the basis of restricted neovascularization through inhibition of MCs in lung and stomach tumors, may be a treatment method.
tumoral and peritumoral fields, as well as vascular structures with luminal and monocellular appearances in the intratumoral field, were counted in each sample. Ten magnification fields were analyzed for each sample. In stomach and lung cases, the non-necrotizing group exhibited a greater number of MC and vascular structures in total. In ovarian cases, more MCs were counted overall in the necrotizing group, but there were fewer vascular structures. The increase in the number of MC and vascular structures in lungs and stomach in the non-necrotizing group supports the theory that MCs are involved in tumor progression. Necrosis, which can be induced on the basis of restricted neovascularization through inhibition of MCs in lung and stomach tumors, may be a treatment method.
REFERENCES (38)
1.
Maltby S, Khazaie K, McNagny KM. Mast cells in tumor growth: angiogenesis, tissue remodeling and immune-modulation. Biochim Biophys Acta 2009; 1796: 19-26.
2.
Antonopoulos D, Tsilioni I, Balatsos NAA, et al. The mast cell – neurofibromatosis connection. J Biol Regul Homeost Agents 2019; 33: 657-659.
3.
de Noronha Santos Netto J, Pires FR, da Fonseca EC, et al. Evaluation of mast cells in periapical cysts, dentigerous cysts, and keratocystic odontogenic tumors. J Oral Pathol Med 2012; 41: 630-636.
4.
Conti P, Lessiani G, Kritas SK, et al. Mast cells emerge as mediators of atherosclerosis: Special emphasis on IL-37 inhibition. Tissue Cell 2017; 49: 393-400.
5.
Taracanowa A, Tsilioni I, Conti P, et al. Substance P and IL-33 administared together stimulate a marked secretion of IL-1β from human mast cells, inhibited by methoxyluteolin. Proc Natl Acad Sci USA 2018; 115: E9381-E9391.
6.
Gallenga CE, Pandolfi F, Caraffa Al, et al. Interleukin-1 family cytokines and mast cells: activation and inhibition. J Biol Regul Homeost Agents 2019; 33: 1-6.
7.
Karaca T. ve Yörük M. 2005 Mast Hücre Heterojenitesi. YYÜ Vet Fak Derg 2005; 16: 57-60.
9.
Galli SJ. New insights into “the riddle of the mast cells”: microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 1990; 62: 5-33.
11.
Weidner N, Austen KF. Ultrastructural and immunohistochemical characterization of normal mast cells at multiple body sites. J Invest Dermatol 1991; 96: 26S-31S.
12.
Cheema VS, Ramesh V, Balamurali PD. The Relevance of mast cells in oral squamous cell carcinoma. J Clin Diagn Res 2012; 6: 1803-1807.
13.
Jahanshahi G, Sabaghian M. Comparative immunohistochemical analysis of angiogenesis and mast cell density in oral normal mucosa and squamous cell carcinoma. Dent Res J (Isfahan) 2012; 9: 8-12.
14.
Kalra M, Rao N, Nanda K, et al. The role of mast cells on angiogenesis in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 2012; 17: 190-196.
15.
Sharma B, Sriram G, Saraswathi TR, Sivapathasundharam B. Immunohistochemical evaluation of mast cells and angiogenesis in oral squamous cell carcinoma. Indian J Dent Res 2010; 21: 260-265.
16.
Michailidou EZ, Markopoulos AK, Antoniades DZ. Mast cells and angiogenesis in oral malignant and premalignant lesions. Open Dent J 2008; 2: 126-132.
17.
Ribatti D, Guidolin D, Marzullo A, et al. Mast cells and angiogenesis in gastric carcinoma. Int J Exp Pathol 2010; 91: 350-356.
18.
della Rovere F, Granata A, Familiari D, et al. Mast cells in invasive ductal breast cancer: different behavior in high and minimum hormone-receptive cancers. Anticancer Res 2007; 27: 2465-2471.
19.
Ribatti D, Finato N, Crivellato E, et al. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol 2005; 193: 1961-1965.
20.
Benítez-Bribiesca L, Wong A, Utrera D, Castellanos E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 2001; 49: 1061-1062.
21.
Donelan J, Boucher W, Papadopoulou N, et al. Corticotropin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process. Proc Natl Acad Sci USA 2006; 103: 7759-7764.
22.
Vanconcelos RAT, Guimaraes CP, Vieira TM, et al. Prognostic significance of mast cell and microvascular densiities in malignant peripheral nerve sheath tumor with and withouth neurofibromatosis type 1. Cancer Med 2019; 8: 972-981.
23.
Ribatti D, Crivellato E, Roccaro AM, et al. Mast cell contribution to angiogenesis related to tumour progression. Clin Exp Allergy 2004; 34: 1660-1664.
24.
Erkiliç S, Erbağci Z. The significance of mast cells associated with basal cell carcinoma. J Dermatol 2001; 28: 312-315.
25.
Hiromatsu Y, Toda S. Mast cells and angiogenesis. Microsc Res Tec 2003; 60: 64-69.
26.
Roche WR. The nature and significance of tumour-associated mast cells. J Pathol 1986; 148: 175-182.
27.
Achen MG, McColl BK, Stacker SA. Focus on lymphangiogenesis in tumor metastasis. Cancer Cell 2005; 7: 121-127.
28.
Ueda T, Aozasa K, Tsujimoto M, et al. Prognostic significance of mast cells in soft tissue sarcoma. Cancer 1988; 62: 2416-2419.
29.
Nechushtan H, Razin E. Regulation of mast cell growth and proliferation. Crit Rev Oncol Hematol 1996; 23: 131-150.
30.
Jiang YA, Zhang YY, Luo HS, Xing SF. Mast cell density and the context of clinicopathological parameters and expression of p185, estrogen receptor, and proliferating cell nuclear antigen in gastric carcinoma. World J Gastroenterol 2002; 8: 1005-1008.
31.
Acikalin MF, Oner U, Topçu I, et al. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Dig Liver Dis 2005; 37: 162-169.
32.
Konukoğlu D. Anjiyogenezin temel moleküler mekanizmaları ve tümör anjiyogenezi. Cerrahpaşa J Med 2005; 36: 42-48.
33.
Blair RJ, Meng H, Marchese MJ, et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997; 99: 2691-2700.
34.
Pyziak L, Stasikowska-Kanicka O, Danilewicz M, W¹growska-Danilewicz M. Immunohistochemical analysis of mast cell infiltrates and microvessel density in oral squamous cell cersinoma. Pol J Pathol 2013; 64: 276-280.
35.
Kouhsoltani M, Halimi M, Dibazar S. A positive correlation between immunohistochemical expression of CD31 and mast cell tryptase in odontogenic tumors. Pol J Pathol 2015; 66: 170-175.
36.
Bia³as M, Dyduch G, Szpor J, et al. Microvascular density and mast cells in benign and malignant pheochromocytomas. Pol J Pathol 2012; 63: 235-242.
37.
Souza LR, Fonseca-Silva T, Santos C, et al. Association of mast cell, eosinophil leucocyte and microvessel densities in actinic cheilitis and lip squamous cell carcinoma. Histopathology 2010; 57: 796-805.
38.
Göksu Erol AY. Mast Hücrelerinin Kanser ve Anjiyogenezde Yeni Tanımlanan Rolleri. Van Tıp Dergisi 2013; 20: 189-193.
Share
RELATED ARTICLE
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
